Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Investigacion Clinica (Venezuela) is Scopus-indexed (Q4, CiteScore 0.4), WoS SCIE. Published by Instituto de Investigaciones Clinicas.
Checked against the index lists dated .
ISSN 0535-5133Verify ISSN ↗2477-9393Verify ISSN ↗
Publisher: Instituto de Investigaciones Clinicas
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 539 / 669 | 19th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1988–present (also 1972–1986, 1961), best quartile Q4, CiteScore 0.4.
Investigacion Clinica (Venezuela) is Q4 in Medicine (all) (rank 539 of 669), by CiteScore 2025.
Investigacion Clinica (Venezuela) is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.4, which places it in quartile Q4 at the 19th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.135, quartile Q4, with an H-index of 25.
Investigacion Clinica (Venezuela) is published by Instituto de Investigaciones Clinicas. Its print ISSN is 0535-5133 and its online ISSN is 2477-9393.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Investigacion Clinica (Venezuela) has an h-index of 10 and a 2-year mean of 0.34 citations per paper (OpenAlex). Its Scopus CiteScore is 0.4, quartile Q4. On 2-year citations it ranks #412 of 646 Scopus journals in Medicine (all).
Investigacion Clinica (Venezuela) published 42 papers in 2025; its busiest recent year was 2019 with 202. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 90 research articles (2024–2026), authors are most often from China (61.1%), Venezuela (16.2%) and Türkiye (5.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.